Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003 April 27, 2021 TORONTO–(BUSINESS WIRE)–Cybin Selects Alcohol Use Disorder Indication for Psychedelic Molecule CYB003 ← P.E.I. BioAlliance executive director reflects on the sector’s growthOrganic Garage Finalizes Its Transition to a Decentralized Distribution Model; Anticipates Savings of $1M Annually →
